Supporting Fetal Alcohol Spectrum Disorders Screening and Intervention
ID: 349429Type: Posted
Overview

Buyer

Health Resources and Services Administration (HHS-HRSA)

Award Range

$0 - $950K

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Cooperative Agreement

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes
Timeline
  1. 1
    Forecast Posted Not available
  2. 2
    Forecast Due Not available
  3. 3
    Posted Apr 3, 2024 12:00 AM
  4. 4
    Due Jun 21, 2024 12:00 AM
Description

The Health Resources and Services Administration is offering a federal grant for the Supporting Fetal Alcohol Spectrum Disorders Screening and Intervention program. This program aims to reduce alcohol use during pregnancy and improve outcomes for children with FASD nationwide, particularly in communities with high rates of binge drinking during pregnancy. The program focuses on educating Primary Care Providers (PCPs) and increasing the use of screening, intervention, and referral processes for high-risk pregnancies. It also aims to enhance PCPs' knowledge of the risks of drinking alcohol during pregnancy and promote recommended screenings, interventions, and referral approaches. Additionally, PCPs who provide healthcare to children and adolescents will develop skills to identify and manage FASD, with an emphasis on effective communication with families. The program plans to engage a minimum of 80 practices over 5 years, with a focus on rural areas and medically underserved communities. The grant has an award ceiling of $950,000 and does not require cost sharing or matching. All domestic public or private entities, including nonprofits, for-profit organizations, small businesses, and various government entities, are eligible to apply. For more information, visit the grant opportunity page: link. For inquiries, contact M. Sonsy Fermin at (301)443-1702 or email wellwomancare@hrsa.gov.

Point(s) of Contact
Files
Title
Posted
Similar Opportunities
Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R61/R33 Clinical Trial Optional)
Active
National Institutes of Health
The National Institutes of Health is offering a grant opportunity titled "Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R61/R33 Clinical Trial Optional)". This grant aims to support research on prevention and intervention strategies for fetal alcohol spectrum disorders (FASD) throughout the lifespan. The grant will focus on reducing prenatal alcohol exposure and the incidence of FASD through prevention approaches, as well as developing interventions for FASD. The grant will be awarded through the Exploratory/Developmental Phased Award (R61/R33) mechanism, with the R61 phase supporting pilot studies and hypothesis development, and the R33 phase allowing for expanded research testing. Priority will be given to applications with clinical trials. Other eligible applicants include various institutions, organizations, and agencies. The grant has a closing date of November 16, 2026, and an award ceiling of $350,000. For more information and to apply, visit the following link: [Grant Information](http://grants.nih.gov/grants/guide/pa-files/PAR-24-068.html).
Community-Based Maternal Behavioral Health Services Program
Active
Substance Abuse and Mental Health Services Adminis
The Substance Abuse and Mental Health Services Administration (SAMHSA) is offering a grant opportunity called the Community-Based Maternal Behavioral Health Services Program. This program aims to improve access to evidence-based, timely, and culturally relevant maternal mental health and substance use (behavioral health) intervention and treatment by strengthening community referral pathways. The grant recipients will be expected to collaborate with pregnancy and postpartum healthcare organizations, refer individuals in need of behavioral health care to the appropriate entities, and provide short-term mental health and substance use services to individuals who cannot access care. Eligible applicants for this grant include State, local, Tribal, and territorial governments, Tribal organizations, nonprofit community-based entities, and primary care and behavioral health organizations. The program seeks to address community behavioral health needs worsened by the COVID-19 public health emergency. The total program funding available is $15,000,000, with an expected number of six awards. The award ceiling is $500,000, and there is no cost sharing or matching requirement. For more information and to apply for the grant, please visit the following link: [Community-Based Maternal Behavioral Health Services Program](https://www.samhsa.gov/grants/grant-announcements/sm-24-013). If you have any questions or need further assistance, you can contact the Office of Financial Resources, Division of Grants Management at SAMHSA through email at FOACMHS@samhsa.hhs.gov or by calling (240) 276-1940.
Alcohol Health Services Research (R34 Clinical Trial Optional)
Active
National Institutes of Health
The National Institutes of Health is offering a grant opportunity titled "Alcohol Health Services Research (R34 Clinical Trial Optional)". This grant aims to address the treatment gap for individuals with alcohol use disorder (AUD) by focusing on alcohol health services. The grant seeks to increase access to treatment for AUD, make treatment more appealing, examine cost structures and insurance systems, conduct studies on dissemination and implementation of evidence-based approaches, and reduce health disparities for populations facing treatment gaps in AUD. The grant does not require cost sharing or matching. The maximum award ceiling is $450,000. Other eligible applicants include Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISISs), eligible agencies of the Federal Government, faith-based or community-based organizations, Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Indian/Native American Tribal Governments, non-domestic entities, regional organizations, Tribally Controlled Colleges and Universities (TCCUs), and U.S. Territories or Possessions. The closing date for applications is September 7, 2026. For more information and to apply, visit the following link: [Alcohol Health Services Research Grant](http://grants.nih.gov/grants/guide/pa-files/PAR-23-252.html). For any inquiries, contact NIH Grants Information at grantsinfo@nih.gov.
Alcohol Health Services Research (R01 Clinical Trial Optional)
Active
National Institutes of Health
The National Institutes of Health is offering a grant opportunity titled "Alcohol Health Services Research (R01 Clinical Trial Optional)". This grant aims to address the treatment gap for individuals with alcohol use disorder (AUD) by focusing on alcohol health services. The grant seeks to increase access to treatment for AUD, make treatment more appealing, examine cost structures and insurance systems, conduct studies on dissemination and implementation of evidence-based approaches, and reduce health disparities for populations facing treatment gaps in AUD. The grant does not require cost sharing or matching. The maximum award ceiling is $500,000. Other eligible applicants include Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions, eligible agencies of the Federal Government, faith-based or community-based organizations, Hispanic-serving Institutions, Historically Black Colleges and Universities, Indian/Native American Tribal Governments, non-domestic entities, regional organizations, Tribally Controlled Colleges and Universities, and U.S. Territories or Possessions. The closing date for applications is September 7, 2026. For more information and to apply, visit the following link: [Alcohol Health Services Research Grant](http://grants.nih.gov/grants/guide/pa-files/PAR-23-251.html). For any inquiries, contact NIH Grants Information at grantsinfo@nih.gov.
Investigational New Drug (IND)-enabling and Early-Stage Development of Medications to Treat Alcohol Use disorder and Alcohol-Associated Organ Damage (U43/U44 Clinical Trial Optional)
Active
National Institutes of Health
The National Institutes of Health (NIH) is offering a federal grant opportunity titled "Investigational New Drug (IND)-enabling and Early-Stage Development of Medications to Treat Alcohol Use disorder and Alcohol-Associated Organ Damage (U43/U44 Clinical Trial Optional)". This grant aims to support Small Business Innovation Research (SBIR) applications from small business concerns (SBCs) that propose the development of therapeutic agents for the treatment of alcohol use disorder (AUD) and/or alcohol-associated organ damage (AAOD). The grant seeks eligible applicants who have identified a therapeutic candidate with a robust body of background data in the basic science and early discovery phases, ready for transition to the preclinical and clinical phases of development. The candidate should possess favorable properties such as bioactivity, stability, manufacturability, bioavailability, in vivo efficacy, and target engagement consistent with the desired clinical application. Projects responsive to this announcement can be at any point along the drug development continuum, from late discovery to early-stage clinical trials. For small molecules, eligibility requires having small-molecule compounds with proof of desired pharmacological activity. For biologics, the profiling of promising product candidates in animal models of AUD or AAOD is allowed as the earliest entry point. The ultimate goal of this grant is to advance molecules closer to U.S. Food and Drug Administration (FDA) approval. Milestones will be tailored to the proposed project. While early-phase clinical trials are supported, they are not mandatory. Small disadvantaged and women-owned small businesses are encouraged to apply. For more information and to apply, please visit the following link: [http://grants.nih.gov/grants/guide/pa-files/PAR-22-102.html](http://grants.nih.gov/grants/guide/pa-files/PAR-22-102.html). If you have any inquiries, please contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov.